About Us

Contact us
Community Advisory Board
Readers Rep
Careers
Events
Historical Archives
Recent Quotes
My Watchlist
Indicators
Local Stocks
San Diego Stocks
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Global Healthcare Ishares ETF (NY: IXJ )

97.82 -0.20 (-0.20%)
Official Closing Price Updated: 4:10 PM EDT, Sep 27, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 96,370
Open 97.97
Bid (Size) 95.00 (1)
Ask (Size) 147.06 (2)
Prev. Close 98.02
Today's Range 97.80 - 98.42
52wk Range 77.96 - 101.31
Shares Outstanding 437,000
Dividend Yield 1.32%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Novo Nordisk's Shares Go on a Rollercoaster Ride After Earnings
Novo Nordisk fell over 8% after its earnings release but recovered nearly all of those losses the next day. It needs to increase supplies of semaglutide. 
Via MarketBeat
Topics ETFs
Want to Earn More in the Stock Market With Less Effort? Try This Simple Strategy
You don't need to be a stock market expert to earn above-average returns. 
Via The Motley Fool

Performance

YTD
+11.40%
+11.40%
1 Month
-2.40%
-2.40%
3 Month
+5.23%
+5.23%
6 Month
+5.01%
+5.01%
1 Year
+18.50%
+18.50%

More News

Read More
Top ETFs for Every Sector
Via The Motley Fool
Topics ETFs Stocks
Exposures US Equities
Market Mayhem: 3 ETFs to Anchor Your Investments in 2024
Via InvestorPlace
Topics ETFs
Global Healthcare ETFs
Via Talk Markets
Upward Trajectory For Biotech/Pharma M&A: Sector Trends Towards Pre-Pandemic Levels, Forecasts Positive For 2024
Via Benzinga
3 Healthcare Technology Stocks to Improve Lives in 2024
Via InvestorPlace
Worried About a Recession? Stash Your Cash in These 2 ETFs.
Via The Motley Fool
US Supports Delay On COVID Patent Waiver Extension Decision
Via Benzinga
7 Profitable Places to Hide Your Money During a Bear Market
Via InvestorPlace
Why WHO Did Not Recommend Convalescent Plasma Therapy For COVID-19
Via Benzinga
Exposures COVID-19
New Drug Applications Pile Up With FDA As Pandemic Still Sore Spot For Delayed Inspections
Via Benzinga
Exposures Product Safety
UK Rolls Out COVID-19 Antibody Tests For All: What You Need To Know
Via Benzinga
Exposures COVID-19
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.